CEO of UnitedHealthcare, Brian Thompson, shot dead in New York City
The CEO of US healthcare insurance firm UnitedHealthcare Group has been shot dead by a masked gunman outside of the …
The CEO of US healthcare insurance firm UnitedHealthcare Group has been shot dead by a masked gunman outside of the …
The Texas Cardiac Arrhythmia Institute (TCAI) at St David's Medical Center has become the first clinic in the US to …
Reveal Genomics and the Istituto Europeo di Oncologia (IEO) have initiated an impact study of the genomic test, HER2DX, to …
GE HealthCare has submitted a 510(k) application to the US Food and Drug Administration (FDA) for CleaRecon DL, a deep …
Lisata Therapeutics and Kuva Labs have announced a worldwide partnership and licence agreement to develop a new class of advanced …
Seno Medical has secured an innovative technology contract with Vizient Inc for its Imagio breast imaging system, a groundbreaking device …
ShiraTronics has commenced the pivotal RELIEV-CM2 CLINICAL Study of its implantable neuromodulation therapy, designed for chronic migraine treatment. The US Food …
Radiology Partners (RP), the largest radiology practice in the US, is partnering with generative artificial intelligence (genAI) software company RADPAIR …
Bracco Imaging’s US unit Bracco Diagnostics and German medical device manufacturer ulrich have announced 510(k) clearance from the US Food …
US-based medical device company Inari Medical has signed a joint venture deal with life sciences venture fund 6 Capital, successor …
Beyond Air has gained CE mark approval for its LungFit PH system, permitting the marketing of the device within the …
GE HealthCare has entered an agreement to purchase the remaining 50% stake in Nihon Medi-Physics (NMP) from Sumitomo Chemical, aiming …
Novocure is seeking regulatory approval in the US, EU, Japan and other key markets after the Phase III PANOVA-3 pancreatic …
Baxter has issued a correction for its AK 98 haemodialysis machines, with the US Food and Drug Administration (FDA) classifying …
The US Food and Drug Administration (FDA) has granted breakthrough device designation to deepull’s UllCORE bloodstream infection (BSI) test. The test, …